Breaking News on Contract Research, Manufacturing & Clinical Trials

Product news > Phase I-II

Latest news headlines

Products

Suppliers

Big Pharma pools together to tackle emerging market woes

24-May-2012 - A host of Big Pharma firms have come together to participate in a new forum in a bid to boost patient recruitment activities in emerging markets.

PPD says new CEO's Pfizer experience will guide partnerships

24-May-2012 - US CRO Pharmaceutical Product Development (PPD) predicts that new CEO Dave Simmons' ‘pharmaceutical industry experience’ gained at Pfizer will be an asset in guiding partnerships.

'Simplify trial data analysis and look at the bigger picture', says Quanticate

22-May-2012 - Quanticate says it will eliminate unnecessarily “complicated spreadsheets” in clinical trial data analysis after integrating a new simplified web-based program into its own.

Quality research key to Pharma viability say execs at Avoca Summit

16-May-2012 - Ensuring outsourced clinical research is of a high standard is critical to the viability of the pharma sector and requires cross industry collaboration according to leaders gathered at the Avoca Group’s Quality Summit.

US biotech pursues Cetero for drug development delay costs

09-May-2012 - A US biotech is seeking $250,000 from Cetero to cover drug development delays caused by alleged breaches of contract.

Chiltern sets up in Taiwan

02-May-2012 - Chiltern has set up a legal entity in Taiwan that will allow it to establish its own local clinical research operations for the first time.

Cetero warns of “fatal” funding alternatives in defence of sale

23-Apr-2012 - Cetero has hit back at critics of its financing plan by saying use of third-party funders would cause a “likely fatal” fight.

Teva tops list of clients Cetero is re-doing FDA studies for

19-Apr-2012 - Cetero is re-doing studies for Teva, Actavis, Ranbaxy and other generic firms to satisfy FDA concerns about its data, court documents show.

Large pharma firms to boost preclinical offshoring; survey

19-Apr-2012 - Half of large pharma firms plan to offshore more discovery and early-stage work in the next two to five years, a survey found.

Improve patient compliance by designing trials around real life, says expert

16-Apr-2012 - Designing trials around patients’ habits is the key to success in patient compliance, according to online recruitment specialist Rebar Interactive.

Cetero sale time extended after creditors call it “objectionable”

16-Apr-2012 - The Delaware Bankruptcy Court has extended the Cetero sale period by 11 days after some creditors called the timeline “objectionable”.

Cetero execs set for bonuses if buyer is found

12-Apr-2012 - Cetero Research executives want bonuses if they manage to find a buyer for the ailing firm according to documents filed as part of the CRO's bankruptcy case.

Keep the kids in mind when conducting clinical trials, say Clinigene

12-Apr-2012 - Clinigene has called for more companies to consider paediatric applications of drugs from the beginning of their clinical trials.

Regulatory changes: the experts give us their thoughts at DIA Euromeeting

05-Apr-2012 - Regulatory reform was the name of the game at this year’s DIA Euromeeting in Denmark.

Roundup of CRO deals

05-Apr-2012 - Outsourcing-Pharma presents a roundup of recent CRO deals, including agreements at Quintiles, MPI, and AMRI.

Computer games could help paediatric clinical trials, says expert

03-Apr-2012 - Partnering with gaming companies could be the way to overcome patient compliance hurdles in paediatric clinical trials, said CRF at DIA Euromeeting.

'Regulators: Get to the point', say experts at DIA Euromeeting

29-Mar-2012 - “Less bureaucracy and more research” was the Danish Minister of science and innovation’s message to regulators at this week's DIA Euromeeting.

INC updates on plans to close former Kendle office

29-Mar-2012 - INC Research says the closure of former Kendle office in Connecticut will better balance resources and that – where possible – staff will be reassigned.

Cetero eyes fast sale to private equity as FDA agreement nears

29-Mar-2012 - Cetero says it could have new private equity owners in 90 days and an agreed path forward with the FDA in weeks.

Strategic deals boost satisfaction levels but CROs still need to deliver on costs

28-Mar-2012 - New research suggests that – in general - strategic partnerships are working but CROs still need to improve on sponsors’ ‘high priority’ objectives or risk losing deals.

Warnex says suitors interested in remaining divisions

28-Mar-2012 - Contract services firm Warnex says its analytical and bioanalytical divisions have attracted ‘interest’ from buyers that would exceed its current market cap.

CRO Cetero files for bankruptcy protection 8 months after FDA fake document accusations

26-Mar-2012 - Cetero Research has filed for bankruptcy protection eight months after the US FDA said it manipulated samples and faked documents.

Selecting formulation early cuts time to market, says Formac

21-Mar-2012 - Formac Pharmaceuticals says its silica-based delivery platform can help Pharmas pick the best formulations earlier in the drug development process.

inVentiv to buy Kforce Clinical Research for FSP biz boost

20-Mar-2012 - inVentiv Health will stump up $50m for contract staffing firm Kforce Clinical Research (KCR) to ramp up its funcatiuonal service provider (FSP) business.

Indian CROs caught in Dateline sting insist report was "out of context"

12-Mar-2012 - The two Indian CROs implicated in US TV show Dateline’s recent undercover operation have branded the report “unfair” and “out of context”.